A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS4144-TPS4144
Author(s):  
Kim Anna Reiss ◽  
Nita Ahuja ◽  
Stephen Baylin ◽  
Lauren Ann Mauro ◽  
Sheila Linden ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Adjuvant Treatment ◽  
Phase Ii Trial ◽  
Epigenetic Therapy ◽  
Randomized Phase Ii

scholarly journals A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

Cancer ◽  
2008 ◽  
Vol 113 (9) ◽  
pp. 2448-2456 ◽  
Author(s):  
Hideyuki Yoshitomi ◽  
Akira Togawa ◽  
Fumio Kimura ◽  
Hiroshi Ito ◽  
Hiroaki Shimizu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Chemotherapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Randomized Phase Ii

Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer

2019 ◽  
Vol 37 (3) ◽  
pp. 559-566 ◽  
Author(s):  
Vadim S. Koshkin ◽  
Maria C. Mir ◽  
Pedro Barata ◽  
Anita Gul ◽  
Ruby Gupta ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Localized Prostate Cancer ◽  
Randomized Phase Ii

scholarly journals Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

2021 ◽  
Author(s):  
Frank A. Sinicrope ◽  
Thomas R. Viggiano ◽  
Navtej S. Buttar ◽  
Louis M. Wong Kee Song ◽  
Kenneth W. Schroeder ◽  
...  
Keyword(s):  
High Risk ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Randomized Phase Ii ◽  
Colonic Neoplasia ◽  
Polyphenon E
Sign in / Sign up

Export Citation Format

Share Document